Can quetiapine cause tinnitus (ear ringing) and what is the recommended management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Quetiapine Cause Tinnitus?

Quetiapine is not listed as causing tinnitus in its FDA-approved labeling, and there is no established causal relationship between quetiapine and ear ringing. 1

Evidence from FDA Drug Labeling

The FDA label for quetiapine provides comprehensive adverse reaction data from clinical trials involving thousands of patients. Tinnitus does not appear among the adverse reactions occurring at 2% or greater incidence in any of the short-term placebo-controlled trials for schizophrenia, bipolar mania, or bipolar depression 1. The label extensively documents adverse reactions across multiple body systems, but auditory/ototoxic effects are notably absent from these listings.

The most common adverse reactions with quetiapine include:

  • Somnolence (18-57% depending on indication)
  • Dry mouth (9-44%)
  • Dizziness (11-18%)
  • Constipation (8-10%)
  • Weight gain (4-5%)

No mention of tinnitus, hearing loss, or other auditory disturbances appears in the comprehensive adverse reaction tables 1.

Contradictory Research Evidence

There is one theoretical hypothesis suggesting quetiapine might actually reduce tinnitus perception through dopaminergic pathway modulation 2. This 2005 paper proposes that antipsychotics including quetiapine could potentially treat tinnitus by modulating dopaminergic neurotransmitters in brain regions involved in tinnitus perception. However, this remains purely theoretical with no clinical trial evidence supporting quetiapine's efficacy for tinnitus treatment.

A 2024 analysis of the FDA Adverse Event Reporting System (FAERS) database examined drug-related tinnitus reports but quetiapine was not among the top 25 drugs associated with tinnitus 3. The drugs most strongly associated with tinnitus in post-marketing surveillance were duloxetine, ciprofloxacin, and adalimumab—not antipsychotics.

Clinical Context

While antipsychotics as a class have been studied in relation to tinnitus, the evidence specifically implicates chlorpromazine (a first-generation antipsychotic) in one pediatric case report 4, but this does not extend to quetiapine. The mechanism and receptor profile of quetiapine differs substantially from chlorpromazine, making extrapolation inappropriate.

Management Recommendation

If a patient on quetiapine develops tinnitus, investigate alternative causes first 5:

  • Concomitant sensorineural hearing loss (the most common association with bothersome tinnitus)
  • Other ototoxic medications (aminoglycosides, loop diuretics, NSAIDs, chemotherapy agents)
  • Underlying ear pathology (Menière's disease, otosclerosis, acoustic neuroma)
  • Cardiovascular disease or hypertension
  • Recent noise exposure

Do not discontinue quetiapine based solely on temporal association with tinnitus onset unless other causes have been systematically excluded. The AAO-HNS guidelines emphasize that tinnitus requires thorough clinical evaluation to identify treatable underlying pathology 5.

If Tinnitus Persists After Evaluation:

  1. Assess impact on quality of life using validated instruments
  2. Screen for anxiety and depression (which commonly co-occur with bothersome tinnitus and require prompt intervention) 5
  3. Consider evidence-based tinnitus treatments: counseling and cognitive behavioral therapy are the only interventions unanimously recommended across guidelines 6
  4. Evaluate for hearing loss and consider hearing aids if present
  5. Avoid attributing tinnitus to quetiapine without clear rechallenge evidence, as this may deprive patients of necessary psychiatric treatment

Important Caveat

The absence of tinnitus in FDA labeling does not definitively prove quetiapine cannot cause it in rare cases, but the burden of evidence strongly suggests no causal relationship. Post-marketing surveillance data support this conclusion 3.

References

Research

Analysis of Drug-Related Tinnitus Based on the FDA Adverse Event Reporting System Database.

British journal of hospital medicine (London, England : 2005), 2024

Research

A case of tinnitus induced by chlorpromazine in a pediatric patient.

Journal of pharmacology & pharmacotherapeutics, 2014

Guideline

clinical practice guideline: tinnitus executive summary.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.